Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
The Plant Journal : for Cell and Molecular Biology
|
April 22, 2021
Ferroportin 3 is a dual-targeted mitochondrial/chloroplast iron exporter necessary for iron homeostasis in Arabidopsis
Leah J Kim, Kaitlyn M Tsuyuki, Fengling Hu, et al.
Annals of Clinical and Translational Neurology
|
May 7, 2024
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination
Ilya Kister, Ryan Curtin, Amanda L Piquet, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Microbiome
|
June 15, 2020
The skin microbiome of elasmobranchs follows phylosymbiosis, but in teleost fishes, the microbiomes converge
Michael P Doane, Megan M Morris, Bhavya Papudeshi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 16, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
The Plant Journal : for Cell and Molecular Biology
|
April 22, 2021
Ferroportin 3 is a dual-targeted mitochondrial/chloroplast iron exporter necessary for iron homeostasis in Arabidopsis
Leah J Kim, Kaitlyn M Tsuyuki, Fengling Hu, et al.
Annals of Clinical and Translational Neurology
|
May 7, 2024
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination
Ilya Kister, Ryan Curtin, Amanda L Piquet, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Microbiome
|
June 15, 2020
The skin microbiome of elasmobranchs follows phylosymbiosis, but in teleost fishes, the microbiomes converge
Michael P Doane, Megan M Morris, Bhavya Papudeshi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 16, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 4, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, Gerome B Vallejos, Takahisa Mikami, et al.
Page
of 2